Atlas Trials

Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388 in Healthy Subjects

Clinical trial NCT04676893 · UNKNOWN

Trial details

NCT number
NCT04676893
Sponsor
Chong Kun Dang Pharmaceutical
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Hepatitis b
Start date
2021-02-26
Primary completion
2021-05-11
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.